Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 15, 2004

View Archived Issues

Optimized Emt inhibitor shows antiinflammatory activity in vivo

Hemostatic effects of fibrinogen gamma chain dodecapeptide conjugate

Novel VAP-1 inhibitors and their use in macular edema described by Fujisawa

New alpha2C-adrenoceptor antagonists identified at Juvantia

Novel HDAC inhibitors prepared and tested at Oxford GlycoSciences

Ranbaxy researchers present novel muscarinic antagonists

New PKC-theta inhibitors and their use covered by Boehringer Ingelheim patent

Sandoz presents new beta-lactam antibiotic prodrugs

Pharmagene describes furan-based prostanoid EP4 antagonist for migraine therapy

New immunomodulator shows synergistic effect with ciclosporin in mouse heart transplant model

Novel glucagon receptor antagonist by Boehringer Ingelheim

Antinociceptive effects of N-acetylaspartylglutamate peptidase inhibitors in vivo

Combined antiarthritic therapy effective in vivo

New phase IIIb study of Tarceva in advanced NSCLC

Orphan drug designation for ProCord

Schering-Plough and Bayer form strategic alliance

AustCancer acquires North American rights to RP-101

Yentreve launched in Europe

Safinamide studied in phase III trial for Parkinson's

TheraCLEC selected for CMA Pilot 2 program

Mirus Bio enters into research agreement with Genzyme

Phase I trial investigates GVAX prostate cancer vaccine with MDX-010

CollaGenex files for trademark Oracea for rosacea treatment Col-101

Oncomer converts solitary tumor into bloodless mass

Iressa studied in new head-to-head trial for NSCLC

AnorMED to seek SPA for AMD-3100 phase III trials

New data on the therapeutic benefits of exenatide in diabetes

SPA for phase III study of glufosfamide for metastatic pancreatic cancer

FK-778 shows efficacy as an immunosuppressant in a liver transplantation model

Valeant acquires E.U. rights to Tasmar

5-alpha Avocuta active in seborrhea

EO-1606 shows promise in multiple dermatological disease models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...